Cobenfy (Xanomeline / Trospium)

Cobenfy is a medicine used to treat schizophrenia in adults. It's taken as a capsule, usually twice a day. It works on a brain chemical called acetylcholine instead of dopamine, which is different from older schizophrenia medicines.

Brand names:Cobenfy
Medication

What people taking Cobenfy (Xanomeline / Trospium) report

Every report comes from a Lived member, sent anonymously.

Have you tried Cobenfy (Xanomeline / Trospium) for Schizophrenia?

NameHow it went

About Cobenfy (Xanomeline / Trospium)

What It's For

Cobenfy is a prescription capsule used to treat schizophrenia in adults. It combines two medicines, xanomeline and trospium chloride, and was approved in the US in 2024 as the first schizophrenia medicine that targets acetylcholine receptors rather than dopamine receptors. Blocking dopamine had been the basis of antipsychotic treatment for decades. Schizophrenia can cause hallucinations (such as hearing voices), fixed false beliefs and disorganized thinking, along with reduced motivation and social withdrawal. Because it works differently, Cobenfy gives people and their prescribers another option, including for those who have struggled with the side effects of dopamine-blocking antipsychotics, such as weight gain. It is not approved for children or teenagers.

How It Works

Xanomeline activates certain receptors for acetylcholine, a chemical messenger in the brain. It mainly stimulates two subtypes of what are called muscarinic receptors. How this relieves psychotic symptoms is not fully understood, but it does not involve blocking dopamine receptors. Xanomeline can also stimulate acetylcholine receptors in the gut, sweat glands and other parts of the body, which can cause effects such as vomiting, diarrhea, sweating and drooling. Trospium is added to block those receptors, and it acts mainly outside the brain. The pairing is meant to limit those body-wide effects while xanomeline works in the brain.

Dosage & Administration

Cobenfy is taken by mouth twice a day. Each capsule contains a fixed amount of both ingredients, written as two numbers (for example, 100 mg/20 mg means 100 mg of xanomeline and 20 mg of trospium). Treatment starts at the lowest strength for a few days, steps up after that, and may be raised to the highest strength depending on how well it works and how well it is tolerated. Older adults usually start low, go up more slowly and have a lower maximum dose. Timing around food matters: take each dose at least one hour before a meal or at least two hours after one, because food sharply reduces how much trospium, the ingredient that limits side effects, the body absorbs. Swallow the capsules whole and do not open them. Before starting, the prescriber checks liver blood tests and heart rate.

Side Effects

Stomach and bowel effects are the most common: nausea, indigestion, vomiting, constipation, abdominal pain, diarrhea and acid reflux. In the main trials, nausea affected about one person in five, compared with about one in twenty-five on placebo. These effects are often worst in the first weeks or after a dose increase. Cobenfy can also raise heart rate and blood pressure, and some people notice dizziness, dry mouth, blurred vision or sleepiness. Cobenfy can make it hard to empty the bladder, which is more likely in men, older adults and people with an enlarged prostate. Contact the prescriber promptly about trouble starting urination, a weak stream, a feeling the bladder has not emptied or painful urination. Yellowing of the skin or eyes, dark urine or unexplained itching can signal a liver problem and should also be reported right away. Rarely, Cobenfy causes swelling of the face, lips, tongue or throat; call 911 if swelling affects the tongue or throat or makes breathing or swallowing difficult.

Interactions & Warnings

Cobenfy is not used in people who cannot fully empty their bladder, whose stomach empties too slowly (gastric retention), who have moderate or severe liver disease, who have untreated narrow-angle glaucoma (a type of glaucoma that can flare suddenly when the pupils widen), or who have had an allergic reaction to it or to trospium. It is also not recommended for people with mild liver disease, gallbladder or bile duct problems such as symptomatic gallstones, or moderate to severe kidney disease, because these raise the level of the medicine in the body. Other medicines with anticholinergic effects, such as benztropine (often prescribed for movement side effects of other antipsychotics) and some bladder and allergy medicines, can add to dry mouth, constipation and urinary problems. Some antidepressants, including fluoxetine (Prozac), paroxetine (Paxil) and bupropion (Wellbutrin), can raise xanomeline levels and make side effects more likely. Cobenfy can cause dizziness, confusion or sleepiness, so avoid driving until you know how it affects you. There are no human data on Cobenfy in pregnancy or breastfeeding. Untreated schizophrenia also carries real risks during pregnancy, so anyone pregnant or planning pregnancy should weigh the options with their care team rather than stopping on their own.

What to Expect

In the trials that led to approval, people with an acute worsening of schizophrenia improved more on Cobenfy than on placebo over five weeks. Stomach side effects tend to appear early and often ease with time, and the rise in heart rate is greatest in the first weeks and lessens somewhat with continued use. The trials enrolled adults up to age 65, so there is less information for older adults. Compared with dopamine-blocking antipsychotics, Cobenfy appears less likely to cause weight gain, but that comparison comes from analyses pooling different studies rather than from direct head-to-head trials. Because it is new, its long-term benefit and rarer delayed side effects are still being studied. Schizophrenia usually needs ongoing treatment, so follow-up visits focus on symptoms, stomach and bladder side effects, heart rate, blood pressure and, when needed, liver tests.

Questions to Ask Your Doctor

  1. 1.Why might Cobenfy suit me better than the antipsychotics I have taken before, and what would switching involve?
  2. 2.How should I fit the twice-daily, empty-stomach timing around my meals and routine?
  3. 3.What can we do if nausea or constipation make it hard to keep taking it?
  4. 4.Do any of my current medicines, including those for movement side effects, depression, bladder or allergies, need to change?
  5. 5.How will we judge whether it is working, and how long should we give it before considering another option?

Last reviewed • Oct 2026

Educational content, not medical advice.